Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy.

Journal: International journal of clinical oncology
Published Date:

Abstract

BACKGROUND: We investigated the effect of the extent of pelvic lymph node dissection (LND) on biochemical recurrence (BCR) in patients with prostate cancer (PCa) without lymph node involvement (LNI) treated with robot-assisted radical prostatectomy (RARP).

Authors

  • Shuichi Morizane
    Division of Urology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
  • Masashi Honda
    Division of Urology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
  • Ryutaro Shimizu
    Division of Urology, Tottori University Faculty of Medicine, Tottori, Japan.
  • Panagiota Tsounapi
    Division of Urology, Department of Surgery, Tottori University Faculty of Medicine, 36-1, Nishicho, Yonago, Japan.
  • Shogo Teraoka
    Division of Urology, Tottori University Faculty of Medicine, Tottori, Japan.
  • Tetsuya Yumioka
    Division of Urology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
  • Noriya Yamaguchi
    Division of Urology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
  • Bunya Kawamoto
    Division of Urology, Department of Surgery, Tottori University Faculty of Medicine, Yonago, Japan.
  • Hideto Iwamoto
    Division of Urology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.
  • Katsuya Hikita
    Division of Urology, Tottori University Faculty of Medicine, Tottori, Japan.
  • Atsushi Takenaka
    Division of Urology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan.